US EditionNearly a quarter of people on long-acting opioids develop addiction
- The FDA released on Monday a study showing that over 22% of patients prescribed extended-release opioids developed addiction within a year.
- The study, mandated by the FDA in 2013, was delayed for more than a decade and funded by opioid manufacturers including Purdue Pharma.
- The findings reveal a much higher addiction rate than less than 1% claimed in Purdue's marketing during the 1990s and early 2000s opioid expansion.
- Andrew Kolodny called the findings "striking and disturbing" and questioned how drug labels claim safety and effectiveness despite evidence of harm.
- The FDA is holding hearings to consider regulatory changes, including label revisions and limiting approvals for long-acting opioids amidst the ongoing opioid crisis.
20 Articles
20 Articles
The Morning Sun
Nearly a quarter of people on long-acting opioids develop addiction
By Sam Hornblower, Bloomberg News More than one in five people prescribed extended-release painkillers such as OxyContin developed an addiction within a year, according to a newly released study mandated by the U.S. Food and Drug Administration. Related Articles Dog data may help track dangerous disease for humans Government watchdog expects Medicaid work requirement analysis by fall Trump administ…
5 Questions with NCCI’s Jon Sinclair on Opioids, AIS
NCCI's Annual Insights Symposium takes the stage next week, and we were lucky to borrow some time from Jon Sinclair, who will be presenting If Not Opioids, Then What? on May 14 at 10:45 a.m. EDT. Here's what attendees can look forward to from Sinclair's session. Q. Why is the topic of this session important for the industry? JS: Pain is a part of nearly every injured worker’s story. Understanding pain management provides a deeper understanding …
Coverage Details
Bias Distribution
- 89% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
